By Tina Sturgill, senior director of biological sciences and director of site operations, Celsis Analytical Services
During uncertain times, outsourcing laboratory services can make sense — especially as a critical component to a company’s bottom line. Today, more and more life sciences companies are looking at outsourcing laboratory services as a business strategy to drive cost savings and realizing that an array of services can be outsourced in the pharmaceutical and biopharmaceutical industries. These include analytical chemistry and microbiology as well as stability, storage, and testing. In addition, a company can outsource early stage discovery and drug development services, such as evaluating the in vitro ADME-Tox properties of drug candidates or performing chemistry manufacturing and control (CMC), including preformulation and cthat fully characterize drug molecule physicochemical properties.